North China Pharmaceutical Company.,Ltd.’s Net Profit Dropped 8% in First Three Quarters of 2023

North China Pharmaceutical Company.,Ltd. (华北制药股份有限公司) (600812.SH) reported a net profit of 50.4 million yuan in the first three quarters of 2023, down 8% year-on-year.

Meanwhile, the company posted 8 billion yuan in revenue, up 1.3% year-on-year.

At the end of the reporting period, it had 21.5 billion yuan in total assets and 15.2 billion yuan in total liabilities, with a liability-to-asset ratio of 70.9%.